GLOBAL BIOENERGIES overview

PRESS RELEASE Unable to get its cosmetics plant project financed, Global Bioenergies is now focusing all its efforts on SAF opportunities Evry, 17 October 2024 – 07:30 a.m.: After several months of efforts, the Company has been unable to find investors for its 2,500-ton plant dedicated to the cosmetics market, in a highly unfavorable context for the financing of first-of-a-kind projects. The Company is now devoting all its energy to applying its technology to the production of Sustainable...

PRESS RELEASE Global Bioenergies becomes a member of GIFAS Evry, 16 July 2024 – 05:45 p.m.: After successfully passing a selection process led by a panel of experts, Global Bioenergies joins the Groupement des Industries Françaises Aéronautiques et Spatiales (GIFAS), and in particular the StartAir club dedicated to start-ups. The aim of this club is to accelerate collaboration between start-ups and companies in the French aerospace industry. GIFAS, which currently gathers 482 members...

PRESS RELEASE Decarbonizing the aviation sector: Global Bioenergies extends its technological process to the production of e-SAF a unique e-SAF with a record selectivity rate of 95% compared to existing technologies a complementary approach to ASTM-certified SAF technology, substituting a plant-based resource for a synthetic resource Evry, 10 July 2024 – 05:45 p.m.: Global Bioenergies announced today that it has adapted its process for the conversion of plant resources into Sustainable...

PRESS RELEASE Global Bioenergies ISO 9001 certified Evry, 16 April 2024 – 05:45 p.m.: Global Bioenergies (FR0011052257 – ALGBE), a player in industrial biotechnology, announces its ISO 9001:2015 certification, the benchmark for quality worldwide. This certification is the result of 3 years of efforts led by the Company in the implementation of its production and marketing activities. Its main objectives are to ensure the quality of products sold and customer satisfaction, in order to respond...

PRESS RELEASE Global Bioenergies: strong reduction of the loss in 2023 thanks to a significant increase in commercial activity Sales exceeding €3M for the first time Consolidated net loss significantly improved to -€8.7M compared to -€12M in 2022 Gross cash position of €11.7M at 31 December 2023 compared to €8.8M the previous year Successful commercialization of the first tons of Isonaturane™ 12 to several customers including L'Oréal ASTM certification received for the production of...

PRESS RELEASE Global Bioenergies announces the start of a new phase in its collaboration with Shell to develop low-carbon road fuels Evry, 17 January 2024 – 05:45 p.m.: Global Bioenergies (FR0011052257 – ALGBE), a key player in industrial biotechnology, announces that the company has signed a new development contract with Shell Global Solutions (Deutschland) GmbH (“Shell”) to further develop low carbon road fuels. While the previous phases of the collaboration, starting at the end of...

PRESS RELEASE Global Bioenergies strengthens its cash position thanks to several cash inflows coming from public fundings Evry, 15 November 2023 – 05:45 p.m.: Global Bioenergies announces the strengthening of its gross cash position to 14.4 million euros to date (unaudited cash position), and the extension of its financial visibility until early 2025 through the collection of several non-dilutive financing from renowned partners (Bpifrance, ADEME and the European agency BBI-JU within the...